Clinical Research Directory
Browse clinical research sites, groups, and studies.
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
Sponsor: Shanghai Zhongshan Hospital
Summary
Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to include 140 patients admitted to the general ward for subcutaneous insulin therapy, who were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence assisted insulin dosimetry system to adjust the insulin dose to control their blood glucose, and the other group with a physician instituted insulin dosimetry adjustments to control their blood glucose. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.
Official title: Efficacy and Safety of the Artificial Intelligence-assisted Insulin Dose Adjustment System for Glycaemic Control in Patients With Type 2 Diabetes Mellitus in General Wards: a Multicentre, Single-blind, Randomised Controlled Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2024-04-19
Completion Date
2026-05-20
Last Updated
2025-08-06
Healthy Volunteers
No
Conditions
Interventions
AI-assisted insulin dose adjustment model
We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients
doctor's insulin dose adjustment
participants' insulin doses are adjusted by doctors
Locations (1)
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China